Clinical Trial Update: Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing bolus versus intravenous push diltiazem for atrial fibrillation or flutter with rapid ventricular response; status currently UN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Bolus diltiazem (diltiazem)
• Diltiazem (diltiazem)
• Intravenous push diltiazem (diltiazem)

Snippet

Sponsor: Mercy Health Muskegon | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: UNKNOWN